Revive’s drug discovery approach combines bioinformatics and drug development relationships with leading researchers and institutions.
Revive targets opportunities by identifying and investigating potential drugs and plant-based therapies, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, or be developed as new chemical entities.
Revive has a multi-disciplinary scientific team of advisors who are experts in the discovery, development, delivery, manufacturing and marketing of drugs as well as in plant-based sciences.
Revive Therapeutics Appoints Dr. Pritesh Kumar as Scientific Advisor for Cannabinoid-Based Therapeutics
Revive Therapeutics Engages Massachusetts General Hospital for Cystinuria Phase 2 Study
Revive Therapeutics Engages NYU School of Medicine for Cystinuria Phase 2 Study
Revive Therapeutics Ltd. Announces Positive Study Results in Rett Syndrome
Revive Therapeutics Ltd. Announces Results for the Three Months Ended September 30, 2016